APA (7th ed.) Citation

M, K., D, W., R, W., M, S., S, B., C, P., & F, M. (2018). Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy. Pharmacological research, 136, 151. https://doi.org/10.1016/j.phrs.2018.08.019

Chicago Style (17th ed.) Citation

M, Kuske, Westphal D, Wehner R, Schmitz M, Beissert S, Praetorius C, and Meier F. "Immunomodulatory Effects of BRAF and MEK Inhibitors: Implications for Melanoma Therapy." Pharmacological Research 136 (2018): 151. https://doi.org/10.1016/j.phrs.2018.08.019.

MLA (9th ed.) Citation

M, Kuske, et al. "Immunomodulatory Effects of BRAF and MEK Inhibitors: Implications for Melanoma Therapy." Pharmacological Research, vol. 136, 2018, p. 151, https://doi.org/10.1016/j.phrs.2018.08.019.